Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(2.67%)
HKD 0.08
(2.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 484.71 Million HKD | 10.08% |
| 2022 | 440.31 Million HKD | 24.59% |
| 2021 | 353.4 Million HKD | 69.27% |
| 2020 | 208.77 Million HKD | -0.32% |
| 2019 | 209.44 Million HKD | 54.85% |
| 2018 | 135.25 Million HKD | -13.56% |
| 2017 | 156.47 Million HKD | 6.82% |
| 2016 | 146.48 Million HKD | 18.75% |
| 2015 | 123.36 Million HKD | 0.8% |
| 2014 | 122.39 Million HKD | 19.26% |
| 2013 | 102.62 Million HKD | 23.15% |
| 2012 | 83.33 Million HKD | 46.13% |
| 2011 | 57.02 Million HKD | -25.71% |
| 2010 | 76.76 Million HKD | -48.23% |
| 2009 | 148.28 Million HKD | -71.82% |
| 2008 | 526.27 Million HKD | -39.51% |
| 2007 | 869.94 Million HKD | 155.2% |
| 2006 | 340.89 Million HKD | 259.03% |
| 2005 | 94.94 Million HKD | -29.29% |
| 2004 | 134.27 Million HKD | -8.18% |
| 2003 | 146.23 Million HKD | -6.28% |
| 2002 | 156.04 Million HKD | -4.21% |
| 2001 | 162.9 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 136.8 Million HKD | 0.0% |
| 2024 Q1 | 136.8 Million HKD | -41.73% |
| 2023 FY | 484.71 Million HKD | 10.08% |
| 2023 Q1 | 124.96 Million HKD | -48.94% |
| 2023 Q2 | 249.93 Million HKD | 100.0% |
| 2023 Q3 | 117.39 Million HKD | -53.03% |
| 2023 Q4 | 234.78 Million HKD | 100.0% |
| 2022 Q4 | 244.73 Million HKD | 100.0% |
| 2022 Q1 | 97.78 Million HKD | -50.21% |
| 2022 Q2 | 195.57 Million HKD | 100.0% |
| 2022 Q3 | 122.36 Million HKD | -37.43% |
| 2022 FY | 440.31 Million HKD | 24.59% |
| 2021 Q4 | 196.42 Million HKD | 100.0% |
| 2021 Q1 | 78.49 Million HKD | -44.47% |
| 2021 Q2 | 156.98 Million HKD | 100.0% |
| 2021 Q3 | 98.21 Million HKD | -37.44% |
| 2021 FY | 353.4 Million HKD | 69.27% |
| 2020 Q2 | 67.43 Million HKD | 100.0% |
| 2020 FY | 208.77 Million HKD | -0.32% |
| 2020 Q4 | 141.34 Million HKD | 100.0% |
| 2020 Q3 | 70.67 Million HKD | 4.8% |
| 2020 Q1 | 33.71 Million HKD | -69.93% |
| 2019 Q3 | 56.06 Million HKD | -42.38% |
| 2019 Q2 | 97.31 Million HKD | 100.0% |
| 2019 Q1 | 48.65 Million HKD | 28.67% |
| 2019 FY | 209.44 Million HKD | 54.85% |
| 2019 Q4 | 112.13 Million HKD | 100.0% |
| 2018 FY | 135.25 Million HKD | -13.56% |
| 2018 Q1 | 29.81 Million HKD | -36.25% |
| 2018 Q3 | 37.81 Million HKD | 26.84% |
| 2018 Q2 | 29.81 Million HKD | 0.0% |
| 2018 Q4 | 37.81 Million HKD | 0.0% |
| 2017 Q2 | 31.47 Million HKD | 0.0% |
| 2017 Q1 | 31.47 Million HKD | -18.29% |
| 2017 FY | 156.47 Million HKD | 6.82% |
| 2017 Q4 | 46.76 Million HKD | 0.0% |
| 2017 Q3 | 46.76 Million HKD | 48.59% |
| 2016 Q4 | 38.51 Million HKD | 0.0% |
| 2016 Q1 | 34.72 Million HKD | 6.68% |
| 2016 FY | 146.48 Million HKD | 18.75% |
| 2016 Q3 | 38.51 Million HKD | 10.91% |
| 2016 Q2 | 34.72 Million HKD | 0.0% |
| 2015 Q3 | 32.55 Million HKD | 11.75% |
| 2015 Q4 | 32.55 Million HKD | 0.0% |
| 2015 FY | 123.36 Million HKD | 0.8% |
| 2015 Q1 | 29.13 Million HKD | 0.0% |
| 2015 Q2 | 29.13 Million HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 FY | 122.39 Million HKD | 19.26% |
| 2014 Q1 | 23.52 Million HKD | 0.0% |
| 2013 FY | 102.62 Million HKD | 23.15% |
| 2013 Q4 | 23.52 Million HKD | -15.37% |
| 2013 Q3 | 27.79 Million HKD | 0.0% |
| 2013 Q2 | 27.79 Million HKD | 52.54% |
| 2013 Q1 | 18.21 Million HKD | 0.0% |
| 2012 Q1 | 16.25 Million HKD | 0.0% |
| 2012 FY | 83.33 Million HKD | 46.13% |
| 2012 Q4 | 18.21 Million HKD | -22.29% |
| 2012 Q3 | 23.44 Million HKD | 0.0% |
| 2012 Q2 | 23.44 Million HKD | 44.23% |
| 2011 FY | 57.02 Million HKD | -25.71% |
| 2011 Q4 | 16.25 Million HKD | 0.0% |
| 2010 FY | 76.76 Million HKD | -48.23% |
| 2009 FY | 148.28 Million HKD | -71.82% |
| 2008 FY | 526.27 Million HKD | -39.51% |
| 2007 FY | 869.94 Million HKD | 155.2% |
| 2006 FY | 340.89 Million HKD | 259.03% |
| 2005 FY | 94.94 Million HKD | -29.29% |
| 2004 FY | 134.27 Million HKD | -8.18% |
| 2003 FY | 146.23 Million HKD | -6.28% |
| 2002 FY | 156.04 Million HKD | -4.21% |
| 2001 FY | 162.9 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 5.32 Billion HKD | 90.893% |